![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Shaanxi Dasheng Pharmaceutical Tech Co., Ltd. Xi’an Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Bicalutamide, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-174 - Rev 02
This Chemical Type CEP, issued on November 17, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2196 associated with this CEP further emphasizes